Stock Events

Stock Events

Sage Therapeutics (SG7.F) Q4 2024 Earnings

29OctConfirmed

Q2 2024

Q1 2024

Q3 2024

Q4 2024

-1.68

-1.59

-1.5

-1.41

Details

Expected EPS

-1.43691272487

Actual EPS

-1.4140413

Surprise EPS

0.02

Surprise Percent

+1.59%

Description

Sage Therapeutics (SG7.F) has reported earnings of -1.4140413 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.